Welcome to our dedicated page for Tenet Healthcare SEC filings (Ticker: THC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Tenet Healthcare Corporation (NYSE: THC) brings together the company’s official regulatory disclosures, offering a structured view of how this diversified healthcare services organization reports its activities in the general medical and surgical hospitals industry. As a Nevada-incorporated public company with common stock and certain senior notes listed on the New York Stock Exchange, Tenet files a range of documents with the U.S. Securities and Exchange Commission.
Key filings include Form 8-K current reports that describe material events such as quarterly earnings releases, new credit agreements, amendments to letter of credit facilities, and issuances of senior secured first lien notes and senior notes. These filings explain how Tenet structures its debt, the terms of its revolving credit facility and borrowing base, and the use of proceeds from note offerings to redeem or partially redeem existing notes. 8-K reports also cover governance matters like director resignations and adjustments to board size.
Investors can also use this page to access periodic reports such as annual and quarterly filings when available, which provide segment information for the Ambulatory business (United Surgical Partners International) and the Hospital Operations and Services segment, as well as details on Conifer Health Solutions’ revenue cycle and value-based care services. These documents help clarify how Tenet’s hospital, ambulatory and services operations are reflected in its financial statements and risk disclosures.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, such as new debt issuances, covenant terms, or changes in financial outlook. Real-time updates from EDGAR, combined with simplified explanations of complex credit agreements and note indentures, allow users to quickly understand how new filings may relate to Tenet’s capital structure, liquidity, and operational focus.
Tenet Healthcare CEO Saumya Sutaria reported several equity compensation events involving restricted stock units and common shares. He received a grant of 36,092 2026 February restricted stock units that convert into common stock on a one-for-one basis and vest in one-third increments over three years. Previously granted RSUs from 2023 and 2024 vested, with 22,417 and 36,384 units exercised into common stock on February 27, 2026. To cover withholding taxes tied to performance and restricted stock unit vesting, he disposed of 9,282 common shares at $237.58 and 29,919 and 124,959 shares at $239.39 through tax-withholding transactions, not open-market sales. After these movements, Sutaria directly owned 658,523 shares of Tenet Healthcare common stock.
Tenet Healthcare EVP & CFO Sun Park reported equity compensation and related tax-withholding transactions. On February 27, 2026, Park received a grant of 7,520 time-based restricted stock units, which vest in one-third increments over three years and settle in common shares upon vesting.
On the same date, 4,670 restricted stock units from a 2024 award converted into an equal number of common shares. To cover withholding taxes on vested performance share units and restricted stock units, 1,626 and 1,985 common shares were withheld at prices of $237.58 and $239.39, respectively. After these transactions, Park directly held 19,438 shares of Tenet Healthcare common stock.
Tenet Healthcare EVP and CIO Paola M. Arbour reported equity compensation activity, not open‑market trading. On February 27, 2026, 1,868 restricted stock units from a February 2024 grant and 2,799 units from a March 2023 grant converted into an equal number of common shares. To cover withholding taxes upon vesting of performance and time-based restricted stock units, 499, 1,838 and 6,810 common shares were withheld at closing prices of $237.58 and $239.39 per share. After these conversions and tax-withholding dispositions, Arbour directly held 35,791 shares of Tenet Healthcare common stock.
Tenet Healthcare executive Lisa Y. Foo, EVP and Chief Operating Officer, reported several equity-related transactions in company stock. She received a grant of 7,520 restricted stock units dated 2026 February, which convert into common shares on a one-for-one basis. She also exercised 4,670 restricted stock units from a 2024 award and 4,199 units from a 2023 award, increasing her common stock holdings. To cover tax withholding obligations tied to vesting of performance and restricted stock units, 1,838 shares, 4,289 shares, and 13,706 shares of common stock were disposed of at reference prices of $237.58 and $239.39 per share, described as shares withheld for taxes rather than open-market sales. After these transactions, she directly owned 42,053 shares of Tenet Healthcare common stock.
Tenet Healthcare principal accounting officer Scott R. Ramsey reported multiple stock transactions. On March 2, 2026, he completed open-market sales totaling 8,017 shares of common stock at weighted average prices of about $230.98, $233.21, and $233.69, leaving 5,892 shares owned directly. Earlier, on February 27, 2026, restricted stock units from 2023 and 2024 grants converted one-for-one into common shares, and several transactions labeled as tax-withholding dispositions satisfied taxes due on these vestings.
Tenet Healthcare EVP and General Counsel Thomas W. Arnst reported multiple equity transactions. On March 2, 2026, he executed an open-market sale of 24,000 shares of common stock at a weighted average price of about $234.04 per share, leaving him with 8,012 directly held shares.
On February 27, 2026, he received a grant of 7,520 time-based restricted stock units and exercised previously granted restricted stock units from 2023 and 2024, which converted into common stock on a one-for-one basis. Shares totaling 1,496, 4,409, and 14,870 were withheld to cover tax obligations upon vesting at prices based on the closing market price.
Filer submitted a Form 144 reporting a proposed sale of common shares. The filing lists 24,000 shares alongside an amount of $5,616,932.53 and a figure of 86,963,000 tied to the record line, with an 03/02/2026 date and NYSE designation. The securities listed relate to restricted stock vesting on 02/24/2026, 02/27/2026, 02/28/2026, and 03/01/2026
Tenet Healthcare EVP & CFO Sun Park reported the vesting and exercise of 3,800 restricted stock units into 3,800 shares of common stock on February 24, 2026, at a price of $0.00 per share. Following these conversions, Park directly holds 18,379 shares of common stock and 7,602 restricted stock units. The RSUs were granted under the 2019 Stock Incentive Plan on February 24, 2025, vesting in three equal annual installments, with the first one-third vesting on February 24, 2026.
Tenet Healthcare CEO Saumya Sutaria reported an increase in directly owned shares through the vesting of restricted stock units. On February 24, 2026, 18,242 "2025 Restricted Stock Units" were exercised or converted, consistent with their one-for-one conversion into common stock.
The transaction delivered 18,242 shares of common stock at a stated price of $0.00 per share, reflecting settlement of time-based awards rather than an open-market purchase. Following these events, Sutaria directly owned 36,486 restricted stock units and 638,923 shares of common stock, all held as direct ownership.
Footnotes explain that the RSUs were granted under the 2019 Stock Incentive Plan on February 24, 2025, vest in three equal annual installments, and are settled in common stock upon vesting. The reported transaction reflects the first one-third of that grant vesting on February 24, 2026.
Tenet Healthcare executive Paola M. Arbour, EVP and Chief Information Officer, reported the vesting and conversion of equity awards tied to her compensation. On February 24, 2026, 1,267 restricted stock units from her 2025 grant converted into an equal number of shares of Tenet common stock at no exercise price.
The restricted stock units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in three equal annual installments, with this filing covering the first one-third tranche. After these transactions, Arbour directly holds 2,534 restricted stock units and 40,271 shares of common stock, reflecting a routine employee equity vesting rather than an open-market purchase or sale.